메뉴 건너뛰기




Volumn 21, Issue 3, 2009, Pages 540-547

A randomized, phase III multicenter trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin in patients with advanced or metastatic non-small-cell lung cancer

Author keywords

Carboplatin; Gemcitabine; Non platinum doublets; NSCLC; Paclitaxel; Phase III

Indexed keywords

CARBOPLATIN; CIMETIDINE; CORTICOSTEROID; DEXAMETHASONE; DIPHENHYDRAMINE; FAMOTIDINE; GEMCITABINE; GRANULOCYTE COLONY STIMULATING FACTOR; PACLITAXEL; RANITIDINE;

EID: 76149117077     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdp352     Document Type: Article
Times cited : (55)

References (61)
  • 2
    • 0027483467 scopus 로고
    • Screening, diagnosis, and staging of lung cancer
    • Shepherd FA. Screening, diagnosis, and staging of lung cancer. Curr Opin Oncol 1993; 5: 310-322.
    • (1993) Curr Opin Oncol , vol.5 , pp. 310-322
    • Shepherd, F.A.1
  • 3
    • 0028139448 scopus 로고
    • Chemotherapy for advanced non-small-cell lung cancer
    • Walling J. Chemotherapy for advanced non-small-cell lung cancer. Respir Med 1994; 88: 649-657.
    • (1994) Respir Med , vol.88 , pp. 649-657
    • Walling, J.1
  • 4
    • 0028843552 scopus 로고
    • Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials
    • Non-small Cell Lung Cancer Collaborative Group
    • Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ 1995; 311: 899-909.
    • (1995) BMJ , vol.311 , pp. 899-909
  • 5
    • 0027367248 scopus 로고
    • Chemotherapy for advanced non-small-cell lung cancer: how much benefit is enough?
    • Grilli R, Oxman AD, Julian JA. Chemotherapy for advanced non-small-cell lung cancer: how much benefit is enough? J Clin Oncol 1993; 11: 1866-1872.
    • (1993) J Clin Oncol , vol.11 , pp. 1866-1872
    • Grilli, R.1    Oxman, A.D.2    Julian, J.A.3
  • 6
    • 0028031433 scopus 로고
    • Chemotherapy vs supportive care in advanced non-small-cell lung cancer. Results of a meta-analysis of the literature
    • Marino P, Pampallona S, Preatoni A et al. Chemotherapy vs supportive care in advanced non-small-cell lung cancer. Results of a meta-analysis of the literature. Chest 1994; 106: 861-865.
    • (1994) Chest , vol.106 , pp. 861-865
    • Marino, P.1    Pampallona, S.2    Preatoni, A.3
  • 7
    • 0027210487 scopus 로고
    • Polychemotherapy in advanced non small cell lung cancer: a meta-analysis
    • Souquet PJ, Chauvin F, Boissel JP et al. Polychemotherapy in advanced non small cell lung cancer: a meta-analysis. Lancet 1993; 342: 19-21.
    • (1993) Lancet , vol.342 , pp. 19-21
    • Souquet, P.J.1    Chauvin, F.2    Boissel, J.P.3
  • 8
    • 0036729263 scopus 로고    scopus 로고
    • Paclitaxel plus carboplatin versus gemcitabine plus paclitaxel in advanced non-small-cell lung cancer: a phase III randomized trial
    • Kosmidis P, Mylonakis N, Nicolaides C et al. Paclitaxel plus carboplatin versus gemcitabine plus paclitaxel in advanced non-small-cell lung cancer: a phase III randomized trial. J Clin Oncol 2002; 20: 3578-3585.
    • (2002) J Clin Oncol , vol.20 , pp. 3578-3585
    • Kosmidis, P.1    Mylonakis, N.2    Nicolaides, C.3
  • 9
    • 39049111157 scopus 로고    scopus 로고
    • Paclitaxel and gemcitabine versus carboplatin and gemcitabine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group
    • Kosmidis PA, Kalofonos HP, Christodoulou C et al. Paclitaxel and gemcitabine versus carboplatin and gemcitabine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group. Ann Oncol 2008; 19: 115-122.
    • (2008) Ann Oncol , vol.19 , pp. 115-122
    • Kosmidis, P.A.1    Kalofonos, H.P.2    Christodoulou, C.3
  • 10
    • 0036843105 scopus 로고    scopus 로고
    • Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer
    • Scagliotti GV, De Marinis F, Rinaldi M et al. Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer. J Clin Oncol 2002; 20: 4285-4291.
    • (2002) J Clin Oncol , vol.20 , pp. 4285-4291
    • Scagliotti, G.V.1    De Marinis, F.2    Rinaldi, M.3
  • 11
    • 0037050352 scopus 로고    scopus 로고
    • Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer
    • Schiller JH, Harrington D, Belani CP et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 2002; 346: 92-98.
    • (2002) N Engl J Med , vol.346 , pp. 92-98
    • Schiller, J.H.1    Harrington, D.2    Belani, C.P.3
  • 12
    • 37549030869 scopus 로고    scopus 로고
    • Efficacy and side effects of cisplatin- and carboplatin-based doublet chemotherapeutic regimens versus non-platinum-based doublet chemotherapeutic regimens as first line treatment of metastatic non-small cell lung carcinoma: a systematic review of randomized controlled trials
    • Rajeswaran A, Trojan A, Burnand B, Giannelli M. Efficacy and side effects of cisplatin- and carboplatin-based doublet chemotherapeutic regimens versus non-platinum-based doublet chemotherapeutic regimens as first line treatment of metastatic non-small cell lung carcinoma: a systematic review of randomized controlled trials. Lung Cancer 2008; 59: 1-11.
    • (2008) Lung Cancer , vol.59 , pp. 1-11
    • Rajeswaran, A.1    Trojan, A.2    Burnand, B.3    Giannelli, M.4
  • 13
    • 19444365516 scopus 로고    scopus 로고
    • Platinum-based versus non-platinumbased chemotherapy in advanced non-small-cell lung cancer: a meta-analysis of the published literature
    • D'Addario G, Pintilie M, Leighl NB et al. Platinum-based versus non-platinumbased chemotherapy in advanced non-small-cell lung cancer: a meta-analysis of the published literature. J Clin Oncol 2005; 23: 2926-2936.
    • (2005) J Clin Oncol , vol.23 , pp. 2926-2936
    • D'Addario, G.1    Pintilie, M.2    Leighl, N.B.3
  • 14
    • 0029558573 scopus 로고
    • Chemotherapy of advanced inoperable non-small cell lung cancer with paclitaxel: a phase II trial
    • Gatzemeier U, Heckmayer M, Neuhauss R et al. Chemotherapy of advanced inoperable non-small cell lung cancer with paclitaxel: a phase II trial. Semin Oncol 1995; 22: 24-28.
    • (1995) Semin Oncol , vol.22 , pp. 24-28
    • Gatzemeier, U.1    Heckmayer, M.2    Neuhauss, R.3
  • 15
    • 0027412646 scopus 로고
    • Phase II study of taxol in patients with untreated advanced non-small-cell lung cancer
    • Murphy WK, Fossella FV, Winn RJ et al. Phase II study of taxol in patients with untreated advanced non-small-cell lung cancer. J Natl Cancer Inst 1993; 85: 384-388.
    • (1993) J Natl Cancer Inst , vol.85 , pp. 384-388
    • Murphy, W.K.1    Fossella, F.V.2    Winn, R.J.3
  • 16
    • 0026333741 scopus 로고
    • Taxol: twenty years later, the story unfolds
    • Rowinsky EK, Donehower RC. Taxol: twenty years later, the story unfolds. J Natl Cancer Inst 1991; 83: 1778-1781.
    • (1991) J Natl Cancer Inst , vol.83 , pp. 1778-1781
    • Rowinsky, E.K.1    Donehower, R.C.2
  • 17
    • 0033950286 scopus 로고    scopus 로고
    • Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trial
    • Bonomi P, Kim K, Fairclough D et al. Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trial. J Clin Oncol 2000; 18: 623-631.
    • (2000) J Clin Oncol , vol.18 , pp. 623-631
    • Bonomi, P.1    Kim, K.2    Fairclough, D.3
  • 18
    • 0025146178 scopus 로고
    • A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861
    • Klastersky J, Sculier JP, Lacroix H et al. A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861. J Clin Oncol 1990; 8: 1556-1562.
    • (1990) J Clin Oncol , vol.8 , pp. 1556-1562
    • Klastersky, J.1    Sculier, J.P.2    Lacroix, H.3
  • 19
    • 0027360291 scopus 로고
    • Phase I and pharmacologic study of paclitaxel and cisplatin with granulocyte colony-stimulating factor: neuromuscular toxicity is dose-limiting
    • Rowinsky EK, Chaudhry V, Forastiere AA et al. Phase I and pharmacologic study of paclitaxel and cisplatin with granulocyte colony-stimulating factor: neuromuscular toxicity is dose-limiting. J Clin Oncol 1993; 11: 2010-2020.
    • (1993) J Clin Oncol , vol.11 , pp. 2010-2020
    • Rowinsky, E.K.1    Chaudhry, V.2    Forastiere, A.A.3
  • 20
    • 0027993707 scopus 로고
    • Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: a phase II study
    • Abratt RP, Bezwoda WR, Falkson G et al. Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: a phase II study. J Clin Oncol 1994; 12: 1535-1540.
    • (1994) J Clin Oncol , vol.12 , pp. 1535-1540
    • Abratt, R.P.1    Bezwoda, W.R.2    Falkson, G.3
  • 21
    • 0028033227 scopus 로고
    • Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: a phase II study
    • Anderson H, Lund B, Bach F et al. Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: a phase II study. J Clin Oncol 1994; 12: 1821-1826.
    • (1994) J Clin Oncol , vol.12 , pp. 1821-1826
    • Anderson, H.1    Lund, B.2    Bach, F.3
  • 22
    • 0029914387 scopus 로고    scopus 로고
    • Activity of gemcitabine in patients with non-small cell lung cancer: a multicentre, extended phase II study
    • Gatzemeier U, Shepherd FA, Le Chevalier T et al. Activity of gemcitabine in patients with non-small cell lung cancer: a multicentre, extended phase II study. Eur J Cancer 1996; 32A: 243-248.
    • (1996) Eur J Cancer , vol.32 A , pp. 243-248
    • Gatzemeier, U.1    Shepherd, F.A.2    Le Chevalier, T.3
  • 23
    • 0033737428 scopus 로고    scopus 로고
    • The influence of gemcitabine and cisplatin schedule on response and survival in advanced non-small cell lung cancer
    • Shepherd FA, Abratt R, Crino L et al. The influence of gemcitabine and cisplatin schedule on response and survival in advanced non-small cell lung cancer. Lung Cancer 2000; 30: 117-125.
    • (2000) Lung Cancer , vol.30 , pp. 117-125
    • Shepherd, F.A.1    Abratt, R.2    Crino, L.3
  • 24
    • 0031032211 scopus 로고    scopus 로고
    • Weekly gemcitabine with monthly cisplatin: effective chemotherapy for advanced non-small-cell lung cancer
    • Abratt RP, Bezwoda WR, Goedhals L, Hacking DJ. Weekly gemcitabine with monthly cisplatin: effective chemotherapy for advanced non-small-cell lung cancer. J Clin Oncol 1997; 15: 744-749.
    • (1997) J Clin Oncol , vol.15 , pp. 744-749
    • Abratt, R.P.1    Bezwoda, W.R.2    Goedhals, L.3    Hacking, D.J.4
  • 25
    • 17344384670 scopus 로고    scopus 로고
    • Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: a phase II study
    • Crino L, Scagliotti G, Marangolo M et al. Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: a phase II study. J Clin Oncol 1997; 15: 297-303.
    • (1997) J Clin Oncol , vol.15 , pp. 297-303
    • Crino, L.1    Scagliotti, G.2    Marangolo, M.3
  • 26
    • 0000292636 scopus 로고    scopus 로고
    • Activity and tolerability of gemcitabine plus weekly cisplatin in advanced non-small cell lung cancer
    • (Abstr)
    • Green M, Eisenberg P, Kosty M et al. Activity and tolerability of gemcitabine plus weekly cisplatin in advanced non-small cell lung cancer. Proc Am Soc Clin Oncol 1998; 17: 468 (Abstr).
    • (1998) Proc Am Soc Clin Oncol , vol.17 , pp. 468
    • Green, M.1    Eisenberg, P.2    Kosty, M.3
  • 27
    • 0032983664 scopus 로고    scopus 로고
    • Gemcitabine and paclitaxel: pharmacokinetic and pharmacodynamic interactions in patients with non-smallcell lung cancer
    • Kroep JR, Giaccone G, Voorn DA et al. Gemcitabine and paclitaxel: pharmacokinetic and pharmacodynamic interactions in patients with non-smallcell lung cancer. J Clin Oncol 1999; 17: 2190-2197.
    • (1999) J Clin Oncol , vol.17 , pp. 2190-2197
    • Kroep, J.R.1    Giaccone, G.2    Voorn, D.A.3
  • 28
    • 0036806170 scopus 로고    scopus 로고
    • A phase II study of weekly gemcitabine and paclitaxel in patients with previously untreated stage IIIb and IV non-small cell lung cancer
    • Bhatia S, Hanna N, Ansari R et al. A phase II study of weekly gemcitabine and paclitaxel in patients with previously untreated stage IIIb and IV non-small cell lung cancer. Lung Cancer 2002; 38: 73-77.
    • (2002) Lung Cancer , vol.38 , pp. 73-77
    • Bhatia, S.1    Hanna, N.2    Ansari, R.3
  • 29
    • 0000327539 scopus 로고    scopus 로고
    • A phase I trial of gemcitabine plus paclitaxel combination therapy in patients with refractory solid tumors
    • (Abstr)
    • Einhorn L, Raghavan D, Kindler H et al. A phase I trial of gemcitabine plus paclitaxel combination therapy in patients with refractory solid tumors. Proc Am Soc Clin Oncol 1998; 17: 796 (Abstr).
    • (1998) Proc Am Soc Clin Oncol , vol.17 , pp. 796
    • Einhorn, L.1    Raghavan, D.2    Kindler, H.3
  • 30
    • 0001039680 scopus 로고    scopus 로고
    • Phase I/II study of paclitaxel and gemcitabine in advanced non-small cell lung cancer
    • (Abstr 1869)
    • Giaccone G, Smit EF, Laan D et al. Phase I/II study of paclitaxel and gemcitabine in advanced non-small cell lung cancer. Proc Am Soc Clin Oncol 1998; 17: (Abstr 1869).
    • (1998) Proc Am Soc Clin Oncol , vol.17
    • Giaccone, G.1    Smit, E.F.2    Laan, D.3
  • 31
    • 7344264012 scopus 로고    scopus 로고
    • Phase I trial of paclitaxel and gemcitabine administered every two weeks in patients with refractory solid tumors
    • Rothenberg ML, Sharma A, Weiss GR et al. Phase I trial of paclitaxel and gemcitabine administered every two weeks in patients with refractory solid tumors. Ann Oncol 1998; 9: 733-738.
    • (1998) Ann Oncol , vol.9 , pp. 733-738
    • Rothenberg, M.L.1    Sharma, A.2    Weiss, G.R.3
  • 32
    • 0003202030 scopus 로고    scopus 로고
    • Phase II study of carboplatin (C)-gemcitabine (G) in advanced non-small cell lung cancer (NSCLC)
    • (Abstr 2107)
    • Domine M, Casado V, Esteves L. Phase II study of carboplatin (C)-gemcitabine (G) in advanced non-small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 2000; 19: (Abstr 2107).
    • (2000) Proc Am Soc Clin Oncol , vol.19
    • Domine, M.1    Casado, V.2    Esteves, L.3
  • 33
    • 0347600552 scopus 로고    scopus 로고
    • Phase II study of an alternate carboplatin and gemcitabine dosing schedule in advanced non-small-cell lung cancer
    • Mott FE, Cable CT, Sharma N. Phase II study of an alternate carboplatin and gemcitabine dosing schedule in advanced non-small-cell lung cancer. Clin Lung Cancer 2003; 5: 174-176.
    • (2003) Clin Lung Cancer , vol.5 , pp. 174-176
    • Mott, F.E.1    Cable, C.T.2    Sharma, N.3
  • 34
    • 33244494814 scopus 로고    scopus 로고
    • Gemcitabine/carboplatin in patients with metastatic non-small-cell lung cancer: phase II study of 28-day and 21-day schedules
    • Obasaju CK, Ye Z, Bloss LP et al. Gemcitabine/carboplatin in patients with metastatic non-small-cell lung cancer: phase II study of 28-day and 21-day schedules. Clin Lung Cancer 2005; 7: 202-207.
    • (2005) Clin Lung Cancer , vol.7 , pp. 202-207
    • Obasaju, C.K.1    Ye, Z.2    Bloss, L.P.3
  • 35
    • 0024440650 scopus 로고
    • Carboplatin dosage: prospective evaluation of a simple formula based on renal function
    • Calvert AH, Newell DR, Gumbrell LA et al. Carboplatin dosage: prospective evaluation of a simple formula based on renal function. J Clin Oncol 1989; 7: 1748-1756.
    • (1989) J Clin Oncol , vol.7 , pp. 1748-1756
    • Calvert, A.H.1    Newell, D.R.2    Gumbrell, L.A.3
  • 36
    • 0344405536 scopus 로고    scopus 로고
    • Update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based clinical practice guidelines.
    • American Society of Clinical Oncology.
    • American Society of Clinical Oncology. Update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based clinical practice guidelines. J Clin Oncol 1996; 14: 1957-1960.
    • (1996) J Clin Oncol , vol.14 , pp. 1957-1960
    • Sudha, R.1
  • 38
    • 33645762226 scopus 로고
    • A sharper Bonferroni procedure for multiple tests of significance
    • Hochberg Y. A sharper Bonferroni procedure for multiple tests of significance. Biometrika 1988; 75: 800-802.
    • (1988) Biometrika , vol.75 , pp. 800-802
    • Hochberg, Y.1
  • 39
    • 0018687930 scopus 로고
    • A multiple testing procedure for clinical trials
    • O'Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics 1979; 35: 549-556.
    • (1979) Biometrics , vol.35 , pp. 549-556
    • O'Brien, P.C.1    Fleming, T.R.2
  • 40
    • 33845382806 scopus 로고
    • Nonparametric estimation of incomplete observations
    • Kaplan E, Meier P. Nonparametric estimation of incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
    • (1958) J Am Stat Assoc , vol.53 , pp. 457-481
    • Kaplan, E.1    Meier, P.2
  • 41
    • 0020396015 scopus 로고
    • Toxicity and response criteria of the Eastern Cooperative Oncology Group
    • Oken MM, Creech RH, Tormey DC et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982; 5: 649-655.
    • (1982) Am J Clin Oncol , vol.5 , pp. 649-655
    • Oken, M.M.1    Creech, R.H.2    Tormey, D.C.3
  • 42
    • 77949589851 scopus 로고    scopus 로고
    • Cancer Therapy Evaluation Program. NCI Common Toxicity Criteria Version 2.0
    • Cancer Therapy Evaluation Program. NCI Common Toxicity Criteria Version 2.0. 1999.
    • (1999)
  • 43
    • 0029042825 scopus 로고
    • Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument
    • Cella DF, Bonomi AE, Lloyd SR et al. Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument. Lung Cancer 1995; 12: 199-220.
    • (1995) Lung Cancer , vol.12 , pp. 199-220
    • Cella, D.F.1    Bonomi, A.E.2    Lloyd, S.R.3
  • 44
    • 66249139985 scopus 로고    scopus 로고
    • Elderly subgroup analysis of a randomized phase 3 trial of gemcitabine (G) in combination with carboplatin (Cb) or paclitaxel (P) compared to paclitaxel plus carboplatin in advanced (stage IIIB, IV) non-small cell lung cancer (NSCLC)
    • 2007 ASCO Annual Meeting Proceedings Part I(Abstr 7665)
    • Ansari R, Goning R, Socinski MA et al. Elderly subgroup analysis of a randomized phase 3 trial of gemcitabine (G) in combination with carboplatin (Cb) or paclitaxel (P) compared to paclitaxel plus carboplatin in advanced (stage IIIB, IV) non-small cell lung cancer (NSCLC). J Clin Oncol 2007; 25 (Suppl 18): 2007 ASCO Annual Meeting Proceedings Part I(Abstr 7665).
    • (2007) J Clin Oncol , vol.25 , Issue.SUPPL 18
    • Ansari, R.1    Goning, R.2    Socinski, M.A.3
  • 45
    • 77949597762 scopus 로고    scopus 로고
    • Subgroup analysis of African American patients from a randomized phase 3 trial of gemcitabine (G) in combination with carboplatin (Cb) or paclitaxel (P) compared to P plus Cb in advanced (stage IIIB, IV) non-small cell lung cancer (NSCLC)
    • 2007 ASCO Annual Meeting Proceedings Part I (Abstr 7665)
    • Treat J, Goning R, Edelman M et al. Subgroup analysis of African American patients from a randomized phase 3 trial of gemcitabine (G) in combination with carboplatin (Cb) or paclitaxel (P) compared to P plus Cb in advanced (stage IIIB, IV) non-small cell lung cancer (NSCLC). J Clin Oncol 2007; 25 (Suppl 18): 2007 ASCO Annual Meeting Proceedings Part I (Abstr 7665).
    • (2007) J Clin Oncol , vol.25 , Issue.SUPPL 18
    • Treat, J.1    Goning, R.2    Edelman, M.3
  • 46
    • 1342268525 scopus 로고    scopus 로고
    • American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003
    • Pfister DG, Johnson DH, Azzoli CG et al. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003. J Clin Oncol 2004; 22: 330-353.
    • (2004) J Clin Oncol , vol.22 , pp. 330-353
    • Pfister, D.G.1    Johnson, D.H.2    Azzoli, C.G.3
  • 47
    • 0035849269 scopus 로고    scopus 로고
    • Platinum-based and nonplatinum-based chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trial
    • Georgoulias V, Papadakis E, Alexopoulos A et al. Platinum-based and nonplatinum-based chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trial. Lancet 2001; 357: 1478-1484.
    • (2001) Lancet , vol.357 , pp. 1478-1484
    • Georgoulias, V.1    Papadakis, E.2    Alexopoulos, A.3
  • 48
    • 33750224010 scopus 로고    scopus 로고
    • CISCA (cisplatin vs. carboplatin) meta-analysis: an individual patient data meta-analysis comparing cisplatin versus carboplatinbased chemotherapy in first-line treatment of advanced non-small cell lung cancer (NSCLC)
    • 2006 ASCO Annual Meeting Proceedings Part I(Abstr 7011)
    • Ardizzoni A, Tiseo M, Boni L et al. CISCA (cisplatin vs. carboplatin) meta-analysis: an individual patient data meta-analysis comparing cisplatin versus carboplatinbased chemotherapy in first-line treatment of advanced non-small cell lung cancer (NSCLC). J Clin Oncol 2006; 24(18S): 2006 ASCO Annual Meeting Proceedings Part I(Abstr 7011).
    • (2006) J Clin Oncol , vol.24 , Issue.18 S
    • Ardizzoni, A.1    Tiseo, M.2    Boni, L.3
  • 49
    • 5444235920 scopus 로고    scopus 로고
    • Meta-analysis of randomized clinical trials comparing cisplatin to carboplatin in patients with advanced non-small-cell lung cancer
    • Hotta K, Matsuo K, Ueoka H et al. Meta-analysis of randomized clinical trials comparing cisplatin to carboplatin in patients with advanced non-small-cell lung cancer. J Clin Oncol 2004; 22: 3852-3859.
    • (2004) J Clin Oncol , vol.22 , pp. 3852-3859
    • Hotta, K.1    Matsuo, K.2    Ueoka, H.3
  • 50
    • 10844259259 scopus 로고    scopus 로고
    • Are cisplatin and carboplatin equivalent in the treatment of non-small cell lung carcinoma (NSCLC)? Results of a comprehensive review of randomized studies in over 2300 patients
    • 2004 ASCO Annual Meeting Proceedings (Post-Meeting Edition)(Abstr 7068)
    • Zojwalla N, Raftopoulos H, Gralla R. Are cisplatin and carboplatin equivalent in the treatment of non-small cell lung carcinoma (NSCLC)? Results of a comprehensive review of randomized studies in over 2300 patients. J Clin Oncol 2004; 22(14S): 2004 ASCO Annual Meeting Proceedings (Post-Meeting Edition)(Abstr 7068).
    • (2004) J Clin Oncol , vol.22 , Issue.14 S
    • Zojwalla, N.1    Raftopoulos, H.2    Gralla, R.3
  • 51
    • 77949588953 scopus 로고    scopus 로고
    • Gemcitabine (G) plus carboplatin (C) at AUC 5 demonstrates reduced grade 4 thrombocytopenia rate compared to AUC 5.5 in first line therapy of patients with advanced stage NSCLC
    • 2006 ASCO Annual Meeting Proceedings Part I(Abstr 7130)
    • Treat J, Belani C, Schiller J et al. Gemcitabine (G) plus carboplatin (C) at AUC 5 demonstrates reduced grade 4 thrombocytopenia rate compared to AUC 5.5 in first line therapy of patients with advanced stage NSCLC. J Clin Oncol 2006; 24 (18 Suppl): 2006 ASCO Annual Meeting Proceedings Part I(Abstr 7130).
    • (2006) J Clin Oncol , vol.24 , Issue.18 SUPPL
    • Treat, J.1    Belani, C.2    Schiller, J.3
  • 52
    • 34547780057 scopus 로고    scopus 로고
    • Excision repair cross-complementation group 1 predicts progression-free and overall survival in non-small cell lung cancer patients treated with platinum-based chemotherapy
    • Azuma K, Komohara Y, Sasada T et al. Excision repair cross-complementation group 1 predicts progression-free and overall survival in non-small cell lung cancer patients treated with platinum-based chemotherapy. Cancer Sci 2007; 98: 1336-1343.
    • (2007) Cancer Sci , vol.98 , pp. 1336-1343
    • Azuma, K.1    Komohara, Y.2    Sasada, T.3
  • 53
    • 34447573875 scopus 로고    scopus 로고
    • Customizing cisplatin based on quantitative excision repair cross-complementing 1 mRNA expression: a phase III trial in nonsmall-cell lung cancer
    • Cobo M, Isla D, Massuti B et al. Customizing cisplatin based on quantitative excision repair cross-complementing 1 mRNA expression: a phase III trial in nonsmall-cell lung cancer. J Clin Oncol 2007; 25: 2747-2754.
    • (2007) J Clin Oncol , vol.25 , pp. 2747-2754
    • Cobo, M.1    Isla, D.2    Massuti, B.3
  • 54
    • 34447567414 scopus 로고    scopus 로고
    • Feasibility and efficacy of molecular analysis-directed individualized therapy in advanced non-small-cell lung cancer
    • Simon G, Sharma A, Li X et al. Feasibility and efficacy of molecular analysis-directed individualized therapy in advanced non-small-cell lung cancer. J Clin Oncol 2007; 25: 2741-2746.
    • (2007) J Clin Oncol , vol.25 , pp. 2741-2746
    • Simon, G.1    Sharma, A.2    Li, X.3
  • 55
    • 0029950085 scopus 로고    scopus 로고
    • Representation of African-Americans, Hispanics, and whites in National Cancer Institute cancer treatment trials
    • Tejeda HA, Green SB, Trimble EL et al. Representation of African-Americans, Hispanics, and whites in National Cancer Institute cancer treatment trials. J Natl Cancer Inst 1996; 88: 812-816.
    • (1996) J Natl Cancer Inst , vol.88 , pp. 812-816
    • Tejeda, H.A.1    Green, S.B.2    Trimble, E.L.3
  • 56
    • 25444511051 scopus 로고    scopus 로고
    • Randomized phase III trial comparing cisplatin-etoposide to carboplatin-paclitaxel in advanced or metastatic non-small cell lung cancer
    • Belani CP, Lee JS, Socinski MA et al. Randomized phase III trial comparing cisplatin-etoposide to carboplatin-paclitaxel in advanced or metastatic non-small cell lung cancer. Ann Oncol 2005; 16: 1069-1075.
    • (2005) Ann Oncol , vol.16 , pp. 1069-1075
    • Belani, C.P.1    Lee, J.S.2    Socinski, M.A.3
  • 57
    • 0035397994 scopus 로고    scopus 로고
    • Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small-cell lung cancer: a Southwest Oncology Group trial
    • Kelly K, Crowley J, Bunn PA Jr et al. Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small-cell lung cancer: a Southwest Oncology Group trial. J Clin Oncol 2001; 19: 3210-3218.
    • (2001) J Clin Oncol , vol.19 , pp. 3210-3218
    • Kelly, K.1    Crowley, J.2    Bunn P.A., Jr.3
  • 58
    • 16644396077 scopus 로고    scopus 로고
    • Single-agent versus combination chemotherapy in advanced non-small-cell lung cancer: the cancer and leukemia group B (study 9730)
    • Lilenbaum RC, Herndon JE II, List MA et al. Single-agent versus combination chemotherapy in advanced non-small-cell lung cancer: the cancer and leukemia group B (study 9730). J Clin Oncol 2005; 23: 190-196.
    • (2005) J Clin Oncol , vol.23 , pp. 190-196
    • Lilenbaum, R.C.1    Herndon J.E. II2    List, M.A.3
  • 59
    • 0016160043 scopus 로고
    • Proceedings: frequency, diagnosis, and treatment of brain metastases in 247 consecutive patients with bronchogenic carcinoma
    • Newman SJ, Hansen HH. Proceedings: frequency, diagnosis, and treatment of brain metastases in 247 consecutive patients with bronchogenic carcinoma. Cancer 1974; 33: 492-496.
    • (1974) Cancer , vol.33 , pp. 492-496
    • Newman, S.J.1    Hansen, H.H.2
  • 60
    • 0024271627 scopus 로고
    • Brain metastases in adenocarcinoma of the lung: frequency, risk groups, and prognosis
    • Sorensen JB, Hansen HH, Hansen M, Dombernowsky P. Brain metastases in adenocarcinoma of the lung: frequency, risk groups, and prognosis. J Clin Oncol 1988; 6: 1474-1480.
    • (1988) J Clin Oncol , vol.6 , pp. 1474-1480
    • Sorensen, J.B.1    Hansen, H.H.2    Hansen, M.3    Dombernowsky, P.4
  • 61
    • 34247899113 scopus 로고    scopus 로고
    • Does initial staging or tumor histology better identify asymptomatic brain metastases in patients with non-small cell lung cancer?
    • Shi AA, Digumarthy SR, Temel JS et al. Does initial staging or tumor histology better identify asymptomatic brain metastases in patients with non-small cell lung cancer? J Thorac Oncol 2006; 1: 205-210.
    • (2006) J Thorac Oncol , vol.1 , pp. 205-210
    • Shi, A.A.1    Digumarthy, S.R.2    Temel, J.S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.